Tag Archives: Clinical Trials

Rebranding Risk-Based Monitoring in Clinical R&D

With all of the buzz and excitement around risk-based monitoring (RBM), one might expect that the broad adoption of this emerging clinical research paradigm is well underway. Those familiar with the often painfully slow pace of innovation in the area of clinical R&D, however, will not be surprised by the more sobering reality that only […]
Posted in R&D | Also tagged , | Leave a comment

What Drives Patient Interest in Clinical Trials?

By Fred Gebhart. Recruiting patients remains one of the most difficult challenges clinical trial sponsors face. Recognizing that fewer than five percent of eligible adult patients enroll in therapeutic trials, many sponsors have turned to supplemental recruitment, the practice of pre-qualifying community-based patients for referral to clinical trial sites for screening. “The primary reason that […]
Posted in Guest Blog, patient education, R&D | Also tagged | Leave a comment

Experts Tell Congress How to Streamline Clinical Trials

Key to accelerating the discovery and development of new medical therapies is to improve the clinical research process, according to leaders of biopharmaceutical research community. As part of its 21st Century Cures Initiative, the House Energy & Commerce Committee called on representatives of industry and academia to present strategies for reducing regulatory oversight, speeding up […]
Posted in R&D, Regulatory | Also tagged , | Leave a comment

Industry Challenged: “Do More for Teenagers with Cancer”

By Leela Barham. Accessing the latest cancer drugs always seem to be controversial. Not just because of the money but also because of the complexities of accessing treatments during their development. This seems to be especially the case for young people with cancer, according to the UK’s Teenage Cancer Trust. 
Posted in Europe, Global, Guest Blog, R&D | Also tagged , , | Leave a comment

The Decline of Clinical Trials in Central and Eastern Europe

Currently, 66% of clinical trials are conducted in North America, Western Europe and Australia.  The U.S. hosts 49% of clinical trial sites and generates approximately 40% of clinical data.  Other regions have arisen in recent years.  The main reasons behind this globalization trend are the availability of highly skilled professionals in new research markets, lower […]
Posted in Emerging Markets, Europe, Global, R&D | Also tagged , , , , | Leave a comment
  • Categories

  • Meta